Thrombin-activatable fibrinolysis inhibitor and activated factor XII in patients with systemic lupus erythematosus

Thromb Res. 2007;119(1):129-31. doi: 10.1016/j.thromres.2006.01.002. Epub 2006 Feb 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Carboxypeptidase B2 / therapeutic use*
  • Case-Control Studies
  • Cohort Studies
  • Factor XIIa / therapeutic use*
  • Female
  • Hemostasis
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Male
  • Middle Aged
  • Thromboembolism / blood
  • Thromboembolism / prevention & control*

Substances

  • Carboxypeptidase B2
  • Factor XIIa